# Glycemic Durability After Metformin Failure

> **NCT02142309** · PHASE4 · UNKNOWN · sponsor: **University of Campania Luigi Vanvitelli** · enrollment: 450 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Glimepiride
- **DRUG:** Vildagliptin
- **DRUG:** Pioglitazone
- **DRUG:** Canagliflozin

## Key facts

- **NCT ID:** NCT02142309
- **Lead sponsor:** University of Campania Luigi Vanvitelli
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-10
- **Primary completion:** 2015-10
- **Final completion:** 2017-01
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2016-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02142309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02142309, "Glycemic Durability After Metformin Failure". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02142309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*